-
Roivant and Sinovant launch biopharma firm Cytovant Sciences
pharmaceutical-technology
April 09, 2019
Roivant and Sinovant launch biopharma firm Cytovant Sciences
-
3M Drug Delivery Systems Relocates UK R&D
contractpharma
April 02, 2019
New R&D site covers more than 1,300 square meters of specifically-configured laboratory space for the development of inhalation therapies
-
Merck & Co pens $340m pain drug deal with KCL and Wellcome
pharmaphorum
March 12, 2019
Merck & Co has announced a deal with King’s College London (KCL) and Wellcome to investigate a new class of painkillers that could provide an alternative to opioids and their dangerous side-effects.
-
NHS Long Term Plan: focus on R&D and digital innovation
pharmaceutical-technology
January 08, 2019
NHS Long Term Plan to build upon the successes of the health service to data and create a ‘new service model for the 21st century’.
-
Deloitte finds Pharma returns on R&D reach new low
europeanpharmaceuticalreview
January 04, 2019
Deloitte has found a sharp decline in the returns on investment from top pharmaceutical companies, with returns at almost half of what they were in 2010
-
R&D returns fall to lowest level in nine years: Deloitte, GlobalData
biospectrumasia
December 26, 2018
‘Unlocking R&D productivity: Measuring the return from pharmaceutical innovation 2018’ published by Deloitte, reveals that returns are down 1.8 percentage points from 3.7 per cent in 2017, and forecast average peak sale.
-
Can China’s R&D sector shake its reputational issues in 2019?
fiercebiotech
December 26, 2018
While 2018 was a big year for Chinese R&D on the whole, the sector hit the headlines for the wrong reasons.
-
Most pharma firms doing little R&D for poorer patients
pharmaphorum
December 17, 2018
A ranking of pharma companies developing new medicines for low- and middle-income countries has revealed that just five companies are responsible for almost two-thirds of projects.....
-
Most pharma firms doing little R&D for poorer patients
pharmaphorum
November 27, 2018
A ranking of pharma companies developing new medicines for low- and middle-income countries has revealed that just five companies are responsible for almost two-thirds of projects....
-
Strong spending seen in US medical and health R&D over five year period
europeanpharmaceuticalreview
November 22, 2018
The pharmaceutical industry accounted for 67 percent of the total spending on research and development, with federal government accounting for 22 percent…